Correlation between G1 cyclins and HPV in the uterine cervix

International Journal of Gynecological Pathology

Volumn 16, Issue 4, 1997, Pages 339-347

  Cho, Nam Hoon ^a   Kim, Young Tae ^a   Kim, Jae Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Cervix uteri; Cyclin D; Cyclin E; HPV type 16; HPV type 18

Indexed keywords

CYCLIN D1; CYCLIN E; REGULATOR PROTEIN; VIRUS DNA;

ARTICLE; CELL CYCLE G1 PHASE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 0342601413     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199710000-00008     Document Type: Article

References (38)

1. La Thangue NB. Introduction: cell cycle regulation and cancer. Semin Cancer Biol 1995;6:61-2.
2. Hartwell LH, Kastan MB. Cell cycle control and cancer [Review]. Science 1994;266:1821-8.
3. Kreipe H, Parwaresch R. A closer look at the cell cycle. Virch Arch [A] Pathol Anat Histopathol [Editorial] 1993;422:341-3.
4. Motokura T, Arnold A. Cyclin D and oncogenesis. [Review] Curr Opin Genet Dev 1993;3:5-10.
5. Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci USA 1994;91:709-13.
6. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types [see comments]. Science 1994;264:436-40.
7. Bates S, Peters G. Cyclin D as a cellular proto-oncogene. Semin Cancer Biol 1995;6:73-82.
8. Hunter T, Pines J. Cyclins and cancer; cyclin D and CDK inhibitors come to age. Cell 1994;79:573-82.
9. Pines J. Cyclins, CDKs and Cancer. Semin Cancer Biol 1995;6: 63-72.
10. Whyte P. The retinoblastoma protein and its relatives. Semin Cancer Biol 1995;6:83-90.
11. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M. Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 1994;91:2945-9.
12. Adams PD, Kaelin WG. Transcriptional control by E2F. Semin Cancer Biol 1995;6:99-108.
13. Knoblich JA, Sauer K, Jones L, Richardson H, Salt R, Lehner CF. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 1994;77:107-20.
14. Dulic V, Lees E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 1992;257:1958-62.
15. Jiang W, Kahn SM, Zhou P, et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 1993;8:3447-57.
16. Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein. J Pathol 1994;172:237-45.
17. Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 1994;9:707-18.
18. Lukas J, Muller H, Bartkova J, et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 1994;125:625-38.
19. Lam EWF, Morris JDH, Davies R, Crook T, Watson RJ, Vousden KH. HPV 16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J 1994;13: 871-8.
20. Arroyo M, Bagchi S, Raychaudhuri P. Association of the human papillomavirus type 16 E7 protein with the S-phase specific E2F-cyclin A complex. Mol Cell Biol 1993;13:6537-46.
21. Imai Y, Matsushima Y, Sugimura T, Terada M. Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol 1991;65:4966-72.
22. Doeberitz MK, Rittmuller C, Aengeneyndt F, Jansen-Durr P, Spitkovsky D. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol 1994;68:2811-21.
23. Vonsden KH. Regulation of the cell cycle by viral oncoproteins. Semin Cancer Biol 1995;6:109-114.
24. Williams ME, Swerdlow SH, Rosenberg CL, Arnold A. Chromosome 11 translocation breakpoints at the PRAD1/Cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993;7:241-5.
25. Yang WI, Zukerberg LR, Motokura T, Arnold A, Harris NL. Cyclin D1(bcl-1, PRAD) protein expression in low grade B-cell lymphomas and reactive hyperplasia. Am J Pathol 1994;145:86-96.
26. Friedman E, Bale AE, Marx SJ, et al. Genetic abnormalities in sporadic parathyroid adenomas. J Clin Endocrinol Metab 1990; 71:293-7.
27. Theillet C, Adnane J, Szepetowski P, Simon MP, Jeanteur P, Birnbaum D, Gaudray P. BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 1990;5:147-9.
28. Zhang S, Caamano J, Cooper F, Guo X, Klein-Szanto A. Immunohistochemistry of cyclin D1 in human breast cancer. Am J Clin Pathol 1994;102:695-8.
29. Lammie GA, Fanti V, Smith R, et al. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991;6:439-44.
30. Berenson JR, Yang J, Mickel RA. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene 1989;4:1111-6.
31. Jiang W, Zhang Y, Kahn SM, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 1993;90:9026-30.
32. Kurzrock R, Ku S, Talpaz M. Abnormalities in the PRAD(CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines. Cancer 1995;75:584-90.
33. Lorincz AT, Reid R, Jenson AB, Kurman RT. Human papilloma virus infection of the cervix; relative risk associations of 15 common anogenital types. Obstet Gynecol 1992;79:328-37.
34. Cornelissen MT, Bots T, Briet MA, et al. Detection of human papilloma virus types by the polymerase chain reaction and the differentiation between high-risk and low-risk cervical lesions. Virchows Arch B Cell Pathol 1992;62:167-71.
35. Griffin NR, Bevan IS, Lewis FA, Wells M, Young LS. Demonstration of multiple HPV types in normal cervix and in cervical squamous cell carcinoma using the polymerase chain reaction on paraffin wax embedded material. J Clin Pathol 1990;43:52-56.
36. Arenas MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method. J Pathol 1991;165: 301-9.
37. Bauer HM, Ting Y, Grrer CE, et al. Genital human papilloma virus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
38. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic markers for breast cancer. Cancer Res 1994;54:380-5.